B. Yang et al., SIGNAL-TRANSDUCTION PATHWAYS IN MODULATION OF CILIARY BEAT FREQUENCY BY METHACHOLINE, The Annals of otology, rhinology & laryngology, 106(3), 1997, pp. 230-236
The release of endogenous neurotransmitters plays an important role in
the airway mucosal defense system, We studied the in vitro effect of
methacholine, a beta-methyl ester of acetylcholine, on the ciliary bea
t frequency (CBF) of human adenoid explants and its mechanism of actio
n. Tissue explants were cultured at 35 degrees C and covered with 1.0
mi, of culture medium: minimum essential Eagle's medium (MEM) containi
ng L-arginine (1.2 x 10(-3) mol/L). Methacholine was added to the cult
ured tissue at concentrations of 10(-10) 10(-8), and 10(-6) mol/L. The
CBF was determined by phase contrast microscopy and microphotometry.
Methacholine increased CBF in a dose-dependent manner with a maximum i
ncrease of 23.0% +/- 1.8% (p <.001). Atropine (10(-6) mol/L) significa
ntly inhibited the ciliostimulatory effects of methacholine (p <.0007)
. The role of endogenous prostaglandins in methacholine-induced cilios
timulation was determined by treating specimens with a cyclooxygenase
inhibitor (diclofenac sodium). Diclofenac (10(-6) mol/L) significantly
inhibited the ciliostimulatory effects of methacholine (p <.0007). To
determine if nitric oxide (NO) acts as an intermediary in ciliostimul
ation by methacholine, endogenous NO production was inhibited by treat
ing specimens with an L-arginine analog, N-G-nitro L-arginine methyl e
ster (L-NAME), prior to addition of methacholine. L-NAME (10(-6) mol/L
) inhibited the effects of methacholine in L-arginin-free MEM (p <.008
), and this inhibition was reversed by L-arginine (10(-3) mol/L). To f
urther examine the actions of NO in methacholine-induced ciliostimulat
ion, a cyclic guanosine 3'5'-monophosphate (cGMP) kinase inhibitor (KT
-5823) was used, prior to the addition of methacholine. KT-5823 (10(-6
) mol/L) significantly inhibited the effects of methacholine (p <.0001
). Ciliostimulation by methacholine in human upper airway mucosa invol
ves both prostaglandin and NO second messengers and activation of a cG
MP-dependent kinase.